INS and Hyperglycemia: Molecular pathophysiological mechanisms that precede hyperglycemia, or are observed with the clinical symptoms of DM, include, among others, alterations in lipid and amino acid metabolism [3-5], changes in hormone levels (including insulin [6] and adiponectin [7]), increases in adipokine levels [8] and alterations in copper metabolism [9].